Page last updated: 2024-10-21

acebutolol and Aortic Coarctation

acebutolol has been researched along with Aortic Coarctation in 1 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Aortic Coarctation: A birth defect characterized by the narrowing of the AORTA that can be of varying degree and at any point from the transverse arch to the iliac bifurcation. Aortic coarctation causes arterial HYPERTENSION before the point of narrowing and arterial HYPOTENSION beyond the narrowed portion.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lardoux, H1
Battino, A1
Maurice, P1
Corvol, P1
Milliez, P1
Girardet, JP1

Other Studies

1 other study available for acebutolol and Aortic Coarctation

ArticleYear
[Action of beta blockaders in hypertension caused by isthmic aortic coarctation: a new proof in favor of renin-angiotensin system].
    La Nouvelle presse medicale, 1978, Jan-07, Volume: 7, Issue:1

    Topics: Acebutolol; Adolescent; Adult; Angiotensin II; Aortic Coarctation; Child; Female; Humans; Hypertensi

1978